JPWO2019231271A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019231271A5
JPWO2019231271A5 JP2020566834A JP2020566834A JPWO2019231271A5 JP WO2019231271 A5 JPWO2019231271 A5 JP WO2019231271A5 JP 2020566834 A JP2020566834 A JP 2020566834A JP 2020566834 A JP2020566834 A JP 2020566834A JP WO2019231271 A5 JPWO2019231271 A5 JP WO2019231271A5
Authority
JP
Japan
Prior art keywords
present
activation
novel heterocyclic
stat3 protein
suppresses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020566834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525752A (ja
JP7558066B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2019/006554 external-priority patent/WO2019231271A1/en
Publication of JP2021525752A publication Critical patent/JP2021525752A/ja
Publication of JPWO2019231271A5 publication Critical patent/JPWO2019231271A5/ja
Application granted granted Critical
Publication of JP7558066B2 publication Critical patent/JP7558066B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020566834A 2018-05-31 2019-05-31 複素環誘導体及びその使用 Active JP7558066B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180062450 2018-05-31
KR10-2018-0062450 2018-05-31
PCT/KR2019/006554 WO2019231271A1 (en) 2018-05-31 2019-05-31 Heterocyclic derivatives and use thereof

Publications (3)

Publication Number Publication Date
JP2021525752A JP2021525752A (ja) 2021-09-27
JPWO2019231271A5 true JPWO2019231271A5 (ko) 2022-03-31
JP7558066B2 JP7558066B2 (ja) 2024-09-30

Family

ID=68698337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020566834A Active JP7558066B2 (ja) 2018-05-31 2019-05-31 複素環誘導体及びその使用

Country Status (6)

Country Link
US (1) US20210155594A1 (ko)
EP (1) EP3802495A4 (ko)
JP (1) JP7558066B2 (ko)
KR (1) KR102229471B1 (ko)
CN (1) CN112204010B (ko)
WO (1) WO2019231271A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110105237B (zh) * 2019-06-06 2021-12-24 东北师范大学 一种β-偕二氟叠氮化合物及其制备和应用
US11648254B2 (en) 2021-03-02 2023-05-16 Kumquat Biosciences Inc. Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling
CN113845476B (zh) * 2021-11-08 2024-04-30 中国药科大学 一种喹诺酮衍生物及其制备方法和用途
CN114315802B (zh) * 2021-12-14 2023-06-16 西安医学院 一种喹唑啉含氮杂环衍生物及制备方法和用途
AU2023255692A1 (en) 2022-04-20 2024-10-03 Kumquat Biosciences Inc. Macrocyclic heterocycles and uses thereof
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960007566A (ko) * 1994-08-19 1996-03-22 김정규 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
WO2001081345A1 (fr) * 2000-04-20 2001-11-01 Mitsubishi Pharma Corporation Composes d'amides aromatiques
US20070088031A1 (en) 2003-12-04 2007-04-19 Masato Nakano Novel chemical compounds
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US20060074105A1 (en) * 2004-09-20 2006-04-06 Serenex, Inc. Substituted quinoline and quinazoline inhibitors of quinone reductase 2
WO2007013964A1 (en) * 2005-07-22 2007-02-01 Sunesis Pharmaceuticals, Inc. Pyrazolo pyrimidines useful as aurora kinase inhibitors
JP2009523845A (ja) * 2006-01-23 2009-06-25 クリスタルゲノミクス インコーポレーテッド たんぱく質キナーゼの活性を阻害するイミダゾピリジン誘導体、これの製造方法およびこれを含む薬学組成物
WO2008086462A2 (en) * 2007-01-11 2008-07-17 Wyeth AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS
EP2014663A1 (de) * 2007-07-12 2009-01-14 Bayer Schering Pharma AG Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
DE102007032739A1 (de) 2007-07-13 2009-01-15 Merck Patent Gmbh Chinazolinamidderivate
JP5529761B2 (ja) * 2008-02-28 2014-06-25 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング プロテイン・キナーゼ阻害剤とその利用法
AU2009269410B2 (en) 2008-07-10 2013-12-05 General Incorporated Association Pharma Valley Project Supporting Organisation STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
US9006252B2 (en) * 2008-09-26 2015-04-14 National Health Research Institutes Fused multicyclic compounds as protein kinase inhibitors
JP5507567B2 (ja) * 2008-09-26 2014-05-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ１受容体拮抗薬としてのアザインダゾール化合物
NZ595087A (en) 2009-02-11 2013-03-28 Merck Patent Gmbh Novel amino azaheterocyclic carboxamides
WO2012079079A1 (en) 2010-12-10 2012-06-14 President And Fellows Of Harvard College Production of induced pluripotent stem cells
WO2014145512A2 (en) * 2013-03-15 2014-09-18 President And Fellows Of Harvard College Potent small molecule inhibitors of autophagy, and methods of use thereof
PE20210128A1 (es) 2017-08-31 2021-01-19 Abbvie Inc Inhibidores de la ectonucleotido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos

Similar Documents

Publication Publication Date Title
BR112018072542A2 (pt) derivados de piridiniltriazol substituído com amida e usos dos mesmos
EA202192910A1 (ru) Соединения, направленные на белки, и содержащие их фармацевтические композиции, и их терапевтическое применение
PH12019501707A1 (en) N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor
CL2004001011A1 (es) Compuestos azabiciclicos derivados de n-arilsulfonilpiperidinas; inhibidores de la deposicion de la proteina beta amiloide; composicion farmaceutica; y su uso para el tratamiento del alzheimer y enfermedades neurodegenerativas.
MA41496B1 (fr) Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
NO20071875L (no) Bicykliske amider som kinaseinhibitorer
BRPI0713755A8 (pt) composto ou um sal ou solvato do mesmo, uso do composto ou um sal ou salvato do mesmo, composição farmacêutica,e, processo para a preparação de um composto ou um sal ou solvato do mesmo
EA200400162A1 (ru) N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения
BR112017017074A2 (pt) Compostos; sal; bis-tosilatos de n-((s)-5-((1r,2s)-2-(4- fluorofenil)ciclopropilamino)-1-(4-metilpiperazin-1- il)-1-oxopentan-2-il)-4-(1h-1,2,3-triazol-1-il)benzamida; sal de tosilato de um composto; sal de bis- tosilato de um composto; compostos, sais, polimorfos ou solvatos; composições farmacêuticas, método para inibição de kdm1a; métodos para tratamento de uma doença mediada por kdm1a ou globina; método para atingir um efeito em um paciente; método para inibir pelo menos uma função de kdm1a
CY1115940T1 (el) Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων
EA202191991A1 (ru) Новые производные гетеротрициклического соединения и их применение
JOP20210185A1 (ar) مركبات هالو-آلِّيلامين واستخدامها
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
EA202192925A1 (ru) Твердые формы ингибитора glyt1
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
JPWO2019231271A5 (ko)
MX2023007497A (es) Nuevos derivados de quinazolina como inhibidores de sos1 y uso de los mismos.
RU94044534A (ru) Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции
EA200300180A1 (ru) Новые соединения и их применение в качестве ингибиторов транспортера глицина
EA202191477A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
EA202190452A1 (ru) Ингибиторы cdk8/19
BR112022019403A2 (pt) Uso de um derivado de tienopiridona no tratamento de doença renal policística autossômica dominante (drpad)
MX2022004383A (es) Composicion de polvo seco inhalable contra enfermedades pulmonares.
BR0112123A (pt) Composto